Spira, A. I., Papadopoulos, K. P., Kim, D. W., Parikh, A. R., Barve, M. A., Powderly, J. D., Starodub, A., Strickler, J. H., Li, B. T., Oberstein, P. E., Hassan, F., Yang, M., McCleland, M., Lally, S., Lin, W., Sohoni, S., Hong, D. S. (2025). Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.724